Intelligent Investor

ImpediMed Limited (ASX: IPD) - Announcements

Current share price for IPD : $0.093 0.002 (2.11%)

ASX company news and announcements for ImpediMed Limited (IPD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ImpediMed Limited (IPD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ImpediMed Limited (IPD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ImpediMed Limited (IPD)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$188 Notification of Quarterly Results & Investor Conference Call 19 Apr 2024 5:32PM $0.093 $0.093 $0.092 fallen by 0%
$188 Organisational Changes 17 Apr 2024 9:04AM $0.094 $0.093 $0.092 fallen by 1.06%
$188 Notification of cessation of securities - IPD 12 Apr 2024 3:28PM $0.092 $0.093 $0.092 risen by 1.09%
$188 Change of Director's Interest Notice - Ms Janelle Delaney 27 Mar 2024 11:51AM $0.086 $0.093 $0.092 risen by 8.14%
$188 Change in substantial shareholding from AEF 13 Mar 2024 9:04AM $0.110 $0.093 $0.092 fallen by 15.45%
$188 Change in substantial holding 12 Mar 2024 5:00PM $0.110 $0.093 $0.092 fallen by 15.45%
$188 Notification of cessation of securities - IPD 11 Mar 2024 11:35AM $0.120 $0.093 $0.092 fallen by 22.50%
$188 Revised Change of Director's Interest Notice-Mr A Grant 8 Mar 2024 8:25PM $0.120 $0.093 $0.092 fallen by 22.50%
$188 Change of Director's Interest Notice - Ms Janelle Delaney 5 Mar 2024 8:18AM $0.090 $0.093 $0.092 risen by 3.33%
$188 Change of Director's Interest Notice - Ms Emmanuel-Donnelly 4 Mar 2024 8:20AM $0.093 $0.093 $0.092 fallen by 0%
$188 S&P DJI Announces March 2024 Quarterly Rebalance 1 Mar 2024 5:03PM $0.093 $0.093 $0.092 fallen by 0%
$188 Change of Director's Interest Notice - Mr Andrew Grant 1 Mar 2024 12:05PM $0.086 $0.093 $0.092 risen by 8.14%
$188 Investor Presentation 27 Feb 2024 8:28AM $0.086 $0.093 $0.092 risen by 8.14%
$188 ImpediMed 2024 Half-Year Financial Results 27 Feb 2024 8:28AM $0.086 $0.093 $0.092 risen by 8.14%
$188 Appendix 4D and Interim Financial Report 27 Feb 2024 8:27AM $0.086 $0.093 $0.092 risen by 8.14%
$188 Appointment of Chair 26 Feb 2024 1:44PM $0.086 $0.093 $0.092 risen by 8.14%
$188 Notification of buy-back - IPD 22 Feb 2024 8:10AM $0.085 $0.093 $0.092 risen by 9.41%
$188 Notification of half-year results & Investor conference call 21 Feb 2024 8:16AM $0.083 $0.093 $0.092 risen by 12.05%
$188 Revised Security Trading Policy 19 Feb 2024 3:50PM $0.083 $0.093 $0.092 risen by 12.05%
$188 New Clinical Practice Guidance Recommends Use of BIS 14 Feb 2024 9:05AM $0.081 $0.093 $0.092 risen by 14.81%
$188 Quarterly Activities Report and Appendix 4C - Dec-23 Qtr 31 Jan 2024 12:26PM $0.125 $0.093 $0.092 fallen by 25.60%
$188 Notification of Results Release Dates and Conference Call 23 Jan 2024 5:01PM $0.130 $0.093 $0.092 fallen by 28.46%
$188 Composition of Board and Committees 22 Jan 2024 11:44AM $0.135 $0.093 $0.092 fallen by 31.11%
$188 Notification of cessation of securities - IPD 10 Jan 2024 12:48PM $0.150 $0.093 $0.092 fallen by 38%
$188 Dr Bains Appointment and Initial Director's Interest Notice 10 Jan 2024 10:45AM $0.155 $0.093 $0.092 fallen by 40%

1 - 25 of 1006 results

Page 1 of 41

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.